OMER

Omeros Corporation

4.52 USD
-0.01 (-0.22%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Omeros Corporation stock is up 37.8% since 30 days ago. The next earnings date is Mar 11, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 71.43% of the previous 14 March’s closed higher than February. In the last 4 Unusual Options Trades, there were 3 CALLs, 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
14 Feb 18:08 15 Mar, 2024 4.00 CALL 500 1458
16 Feb 15:07 17 Jan, 2025 7.00 CALL 200 211
21 Feb 16:02 16 Aug, 2024 4.00 PUT 300 100
22 Feb 14:54 16 Aug, 2024 5.00 CALL 250 260

About Omeros Corporation

Omeros Corporation discovers, develops, and commercializes small-molecule and protein therapeutics. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA) and atypical hemolytic uremic syndrome (aHUS) The company was incorporated in 1994 and headquartered in Seattle, Washington.